Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CTSA | P10619 | 8/20 | 0.36 |
| ▸ | MC4R | P32245 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28041541 | 0.85 | KDM4E (0.36) | MEN1KMT2AGAAALDH1A1LMNA | |
| SCHEMBL28041534 | 0.85 | MEN1 (0.45) | CNR2MEN1KMT2AGAAALDH1A1 | |
| SCHEMBL28041751 | 0.85 | GAA (0.40) | CNR2MEN1KMT2AGAAALDH1A1 | |
| SCHEMBL28041525 | 0.84 | CTSA (0.39) | MEN1KMT2AALDH1A1CTSA | |
| SCHEMBL16054881 | 0.77 | GAA (0.46) | CNR2MEN1KMT2AGAAALDH1A1 | |
| SCHEMBL28990587 | 0.76 | GAA (0.43) | CNR2MEN1KMT2AGAAALDH1A1 | |
| SCHEMBL27865091 | 0.75 | CNR2 (0.40) | CNR2MEN1KMT2AGAAALDH1A1 | |
| SCHEMBL16067608 | 0.74 | CYP3A4 (0.36) | CNR2MEN1KMT2AGAAALDH1A1 | |
| SCHEMBL28990511 | 0.74 | CYP3A4 (0.36) | CNR2MEN1KMT2AGAAALDH1A1 | |
| SCHEMBL15080167 | 0.73 | MEN1 (0.38) | CNR2MEN1KMT2AGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111419830-B | Phenylalkylcarbamate compounds for use in the prevention or treatment of epilepsy and epileptic related syndromes | 比皮艾思药物研发有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-115996905-A | Phenylalkyl carbamate compounds for use in preventing or treating neurodegenerative diseases | 生物药品解决方案有限公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-111419830-A | Phenylalkylcarbamate compounds for use in the prevention or treatment of epilepsy and epilepsy-related syndromes | 比皮艾思药物研发有限公司 | 2020-07-17 | — | — | CN | disclosed |
| CN-105209027-A | Phenylalkylcarbamate compounds for use in the prevention or treatment of epilepsy and epilepsy-related syndromes | BIO PHARM SOLUTIONS CO LTD | 2015-12-30 | — | — | CN | disclosed |